Series B - Ocunexus Therapeutics
Investment Firm
Overview
Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology.
Announced Date
Apr 18, 2011
Funding Type
Series B
Highlights
Location
United States, North America
Social
N/A
Participant Investors
3
| Investor Name |
|---|
 BioPacific Ventures |
 GBS Ventures |
 Domain Associates |
Round Details and Background
Ocunexus Therapeutics raised $19200000 on 2011-04-18 in Series B
Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 24, 2012 |  Series B - Ocunexus Therapeutics | 4 | - | 20.0M |
| Oct 06, 2011 | Debt Financing - Ocunexus Therapeutics | 1 | - | 6.0M |
| Apr 18, 2011 | Series B - Ocunexus Therapeutics | 3 | - | 19.2M |
| Oct 10, 2006 | Series A - Ocunexus Therapeutics | 2 | - | 20.0M |
Recent Activity
There is no recent news or activity for this profile.